Literature DB >> 16220551

Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.

John Anderson1, Sian Gibson, Dan Williamson, Dyanne Rampling, Catherine Austin, Janet Shipley, Neil Sebire, Penelope Brock.   

Abstract

MYCN amplification and 1p36 deletion are adverse prognostic factors in neuroblastoma, and rapid accurate determination of MYCN amplification is essential for risk stratification. MYCN copy number and 1p36 deletion status were determined by fluorescence in situ hybridization (FISH) and real time PCR in a diagnostic pathology laboratory setting on 35 consecutive patients with neuroblastoma. The PCR technique was technically successful in all cases and results were generally available within 24 hr of biopsy. There was no discordance between FISH and PCR results. Real time PCR is a reliable, accurate, and simple technique that can be applied to small neuroblastoma biopsies allowing rapid diagnosis. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16220551     DOI: 10.1002/pbc.20311

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Association of age at diagnosis and genetic mutations in patients with neuroblastoma.

Authors:  Nai-Kong V Cheung; Jinghui Zhang; Charles Lu; Matthew Parker; Armita Bahrami; Satish K Tickoo; Adriana Heguy; Alberto S Pappo; Sara Federico; James Dalton; Irene Y Cheung; Li Ding; Robert Fulton; Jianmin Wang; Xiang Chen; Jared Becksfort; Jianrong Wu; Catherine A Billups; David Ellison; Elaine R Mardis; Richard K Wilson; James R Downing; Michael A Dyer
Journal:  JAMA       Date:  2012-03-14       Impact factor: 56.272

2.  Fast detection of MYCN copy number alterations in brain neuronal tumors by real-time PCR.

Authors:  S G Malakho; A Korshunov; A M Stroganova; A B Poltaraus
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

3.  Droplet digital PCR as an alternative to FISH for MYCN amplification detection in human neuroblastoma FFPE samples.

Authors:  Dinesh Babu Somasundaram; Sheeja Aravindan; Zhongxin Yu; Muralidharan Jayaraman; Ngoc T B Tran; Shibo Li; Terence S Herman; Natarajan Aravindan
Journal:  BMC Cancer       Date:  2019-01-28       Impact factor: 4.430

4.  MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma.

Authors:  Zhi-Xia Yue; Tian-Yu Xing; Wen Zhao; Qian Zhao; Xi-Si Wang; Yan Su; Chao Gao; Shu-Guang Liu; Xiao-Li Ma
Journal:  Cancer Med       Date:  2022-02-09       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.